<scp>HCV</scp>clearance from saliva of<scp>HIV</scp>–<scp>HCV</scp>‐coinfected patients on treatment with interferon plus ribavirin

Feijoo, Javier Fernández; Eirea, M.; Limeres, Jacobo; Abeleira, María Teresa; Ramos, Irene; Ocampo, Antonio; Dios, Pedro Diz

doi:10.1111/odi.12116

Cited by 3 publications

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We also greatly need better estimates of global HCV costs including oral healthcare needs that continue to be concerning overlooked (Carrozzo, 2001), particularly if comparing to the amount of information available for HIV (Vernon et al, 2014). Preliminary data suggested that HCV-RNA analysis on the saliva could be useful to monitor antiviral treatment (Diz Dios et al, 2005;Feijoo et al, 2014), and further studies are clearly warranted.…”

Section: Challenges and Opportunitiesmentioning

confidence: 99%

Hepatitis C virus: a silent killer relevant to dentistry

Carrozzo

2014

Oral Diseases

View full text Add to dashboard Cite

Around 25 years ago, hepatitis C virus (HCV) was identified, and following intense research and tremendous advancements, the infection is now potentially curable and even complete viral eradication is possible. It is also evident that HCV can be involved in some oral disorders, but more research is clearly warranted on oral health of HCV-infected patients. Given the global estimates on HCV epidemic and its likely huge economic impact, primary prevention and secondary prevention are worldwide priorities. However, investments are still insufficient to achieve these goals. Oral Diseases (2014) 20, 425-429

show abstract

Section: Challenges and Opportunitiesmentioning

confidence: 99%

Hepatitis C virus: a silent killer relevant to dentistry

Carrozzo

2014

Oral Diseases

View full text Add to dashboard Cite

show abstract

Optimization of a real time PCR methodology for HCV RNA quantification in saliva samples

Mendonça

Portilho

Silva

et al. 2022

Journal of Virological Methods

View full text Add to dashboard Cite

Update on hepatitis B and C virus diagnosis

Lm¹,

Hm²,

Barbosa³

et al. 2015

WJV

View full text Add to dashboard Cite

Viral hepatitis B and C virus (HBV and HCV) are responsible for the most of chronic liver disease worldwide and are transmitted by parenteral route, sexual and vertical transmission. One important measure to reduce the burden of these infections is the diagnosis of acute and chronic cases of HBV and HCV. In order to provide an effective diagnosis and monitoring of antiviral treatment, it is important to choose sensitive, rapid, inexpensive, and robust analytical methods. Primary diagnosis of HBV and HCV infection is made by using serological tests for detecting antigens and antibodies against these viruses. In order to confirm primary diagnosis, to quantify viral load, to determine genotypes and resistance mutants for antiviral treatment, qualitative and quantitative molecular tests are used. In this manuscript, we review the current serological and molecular methods for the diagnosis of hepatitis B and C.

show abstract

HCVclearance from saliva ofHIV–HCV‐coinfected patients on treatment with interferon plus ribavirin

Abstract: In HIV-HCV-coinfected patients responders to PEG-IFN-RIB, the salivary glands do not appear to be a sanctuary site for HCV, although viral clearance from saliva may be slower than from blood.

Cited by 3 publications

References 29 publications

Hepatitis C virus: a silent killer relevant to dentistry

Hepatitis C virus: a silent killer relevant to dentistry

Optimization of a real time PCR methodology for HCV RNA quantification in saliva samples

Update on hepatitis B and C virus diagnosis

Contact Info

Product

Resources

About